Tag: clinical testing
May 2, 2018
Kalytera Announces Issuance of Second Patent Covering the Use of CBD in Graft Versus Host Disease
Kalytera Therapeutics, Inc. (TSXV:KALY, OTCQB:KALTF) (the "Company" or "Kalytera") today announced that the U.S. Patent and Trademark Office ("USPTO") issued...
April 30, 2018
Key Stock Catalysts in the FDA Drug Application Process
Pharmaceutical and biotech companies in the US must follow a standard process to advance a new drug candidate through nonclinical...
April 29, 2018
Cannabis Weekly Round-Up: 3 New Cannabis Stocks Set to Launch in Canada
The Investing News Network rounds up some of the biggest company and market news in the cannabis market for the... April 27, 2018
Cannabis Weekly Round-Up: 3 New Cannabis Stocks Set to Launch in Canada
The Investing News Network rounds up some of the biggest company and market news in the cannabis market for the... April 26, 2018
Kalytera Issues CEO Letter to Shareholders
Kalytera Therapeutics, Inc. (TSXV:KALY, OTCQB:KALTF) (the "Company" or "Kalytera") today issued the following letter to shareholders from the Company’s President...
April 12, 2018
Innovation and Opportunities in the CBD Therapeutics Market
Kalytera Therapeutics CEO Bob Farrell shares his insight into the growing market for cannabinoid-based pharma products in this interview.
April 10, 2018